Jim Simons Renaissance Technologies
AUM
$75.2B
1-Year Return
41.49%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Quarter Return
+11.58%
1 Year Return
+41.49%
3 Year Return
+105.58%
5 Year Return
+199.51%
10 Year Return
+593.04%
AUM
$130B
AUM Growth
+$12B
(+10%)
Cap. Flow
+$3.31B
Cap. Flow
% of AUM
2.54%
Top 10 Holdings %
Top 10 Hldgs %
12.68%
Holding
3,913
New
518
Increased
1,840
Reduced
1,085
Closed
444
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$1.76B |
| 2 |
Tesla
TSLA
|
$1.37B |
| 3 |
Amazon
AMZN
|
$623M |
| 4 |
AbbVie
ABBV
|
$398M |
| 5 |
Qualcomm
QCOM
|
$394M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
$603M |
| 3 |
Micron Technology
MU
|
$366M |
| 4 |
Meta Platforms (Facebook)
META
|
$365M |
| 5 |
UnitedHealth
UNH
|
$353M |
Sector Composition
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.91% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Icon
ICLR
$13.6B
| $404M | 0.31% |
2,347,059
+36,099
| +2% | +$6.22M |
|
|
ALXN
52
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $404M | 0.31% |
3,731,144
+881,477
| +31% | +$95.3M |
|
|
MBT
53
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $402M | 0.31% |
39,612,969
+7,005,055
| +21% | +$71.1M |
|
54
Newmont
NEM
$83.7B
| $401M | 0.31% |
9,234,499
+1,966,320
| +27% | +$85.4M |
|
55
Seagate
STX
$40B
| $401M | 0.31% |
6,731,871
+2,494,526
| +59% | +$148M |
|
56
F5
FFIV
$18.1B
| $400M | 0.31% |
2,865,374
+569,200
| +25% | +$79.5M |
|
|
ABMD
57
DELISTED
Abiomed Inc
ABMD
| $396M | 0.3% |
2,323,023
+187,300
| +9% | +$32M |
|
58
Evergy
EVRG
$16.5B
| $390M | 0.3% |
5,986,756
-1,005,700
| -14% | -$65.5M |
|
59
Progressive
PGR
$143B
| $388M | 0.3% |
5,359,886
-414,910
| -7% | -$30M |
|
60
Southern Company
SO
$101B
| $384M | 0.3% |
6,028,863
-2,600,939
| -30% | -$166M |
|
61
Bausch Health
BHC
$2.72B
| $374M | 0.29% |
12,491,799
+7,429,396
| +147% | +$222M |
|
62
Teradyne
TER
$19.1B
| $368M | 0.28% |
5,401,749
-157,476
| -3% | -$10.7M |
|
|
HZNP
63
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $366M | 0.28% |
10,100,675
+750,100
| +8% | +$27.2M |
|
64
Consolidated Edison
ED
$35.4B
| $362M | 0.28% |
4,006,694
-273,706
| -6% | -$24.8M |
|
65
MarketAxess Holdings
MKTX
$7.01B
| $362M | 0.28% |
955,954
+237,744
| +33% | +$90.1M |
|
66
Ameren
AEE
$27.2B
| $351M | 0.27% |
4,571,208
-1,034,392
| -18% | -$79.4M |
|
67
Fox Class A
FOXA
$27.4B
| $347M | 0.27% |
9,349,489
+701,400
| +8% | +$26M |
|
68
NetEase
NTES
$85B
| $345M | 0.27% |
5,623,585
+3,492,085
| +164% | +$214M |
|
69
CSX Corp
CSX
$60.6B
| $341M | 0.26% |
14,142,675
+6,307,557
| +81% | +$152M |
|
70
NetApp
NTAP
$23.7B
| $340M | 0.26% |
5,464,940
-1,304,232
| -19% | -$81.2M |
|
71
Equity Lifestyle Properties
ELS
$12B
| $335M | 0.26% |
4,754,130
-327,472
| -6% | -$23.1M |
|
72
Public Storage
PSA
$52.2B
| $326M | 0.25% |
1,531,872
+11,915
| +0.8% | +$2.54M |
|
73
Vale
VALE
$44.4B
| $324M | 0.25% |
24,511,590
-7,169,700
| -23% | -$94.6M |
|
74
Colgate-Palmolive
CL
$68.8B
| $322M | 0.25% |
4,672,627
+109,900
| +2% | +$7.57M |
|
75
Exelixis
EXEL
$10.2B
| $316M | 0.24% |
17,953,926
+3,104,330
| +21% | +$54.7M |
|